Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders

29Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BACKGROUND: In order to optimally integrate the use of high-throughput sequencing (HTS) as a tool in clinical diagnostics of likely monogenic disorders, we have created a multidisciplinary "Genome Clinic Task Force" at the University Hospitals of Geneva, which is composed of clinical and molecular geneticists, bioinformaticians, technicians, bioethicists, and a coordinator. METHODS AND RESULTS: We have implemented whole exome sequencing (WES) with subsequent targeted bioinformatics analysis of gene lists for specific disorders. Clinical cases of heterogeneous Mendelian disorders that could potentially benefit from HTS are presented and discussed during the sessions of the task force. Debate concerning the interpretation of identified variants and the content of the final report constitutes a major part of the task force's work. Furthermore, issues related to bioethics, genetic counseling, quality control, and reimbursement are also addressed. CONCLUSIONS: This multidisciplinary task force has enabled us to create a platform for regular exchanges between all involved experts in order to deal with the multiple complex issues related to HTS in clinical practice and to continuously improve the diagnostic use of HTS. In addition, this task force was instrumental to formally approve the reimbursement of HTS for molecular diagnosis of Mendelian disorders in Switzerland.

Figures

  • Fig. 1 Organization chart of the Genome Clinic Task Force
  • Fig. 2 Overview of the practical steps (1–9) of the Genome Clinic Task Force
  • Table 1 Databases and tools routinely used for variant annotation and classification. Additional databases and tools are used as deemed necessary
  • Fig. 3 Results of targeted gene analysis in 47 patients with developmental delay. Pathogenic variants were identified in 28 %, VUS in 23 %, and no pathogenic variants were found in 49 % of the patients, respectively
  • Fig. 4 Results of targeted gene analysis in 92 patients with various Mendelian diseases. Pathogenic variants were found in 46 %, VUS in 10 %, and no pathogenic variants were found in 45 % of the patients, respectively
  • Table 2 Causative variants identified in the resolved cases
  • Table 2 Causative variants identified in the resolved cases (Continued)

Cited by Powered by Scopus

Molecular insights into cardiomyopathies associated with desmin (DES) mutations

103Citations
N/AReaders
Get full text

De novo mutations and rare variants occurring in NMDA receptors

99Citations
N/AReaders
Get full text

Distinct roles of GRIN2A and GRIN2B variants in neurological conditions.

88Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Fokstuen, S., Makrythanasis, P., Hammar, E., Guipponi, M., Ranza, E., Varvagiannis, K., … Antonarakis, S. E. (2016, June 28). Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders. Human Genomics. https://doi.org/10.1186/s40246-016-0080-4

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

38%

Researcher 11

38%

Professor / Associate Prof. 5

17%

Lecturer / Post doc 2

7%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 14

54%

Medicine and Dentistry 6

23%

Agricultural and Biological Sciences 4

15%

Computer Science 2

8%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 46

Save time finding and organizing research with Mendeley

Sign up for free
0